Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Marques

Showing results (201-210 of 1,073) with videos related to

Pageof 108
Sort By:
Advanced Biomedical Research|March 11, 2026
Comparison of the 5-Year Incidence of Dyslipidemia in the Obese and Nonobese Adult Population: Results of the Yazd Health Study (YaHS)Parisa Peigan, Masoud Mirzaei, Pedro Marques-Vidal, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Soluble CD14 and Lipopolysaccharide-Binding Protein Are Not Superior to Soluble CD25 as Biomarkers for SarcoidosisSabine Ammann, Pedro Marques-Vidal, Matthieu Perreau, et al.
Diabetes Care|June 4, 2011
Estimating the risk of developing type 2 diabetes: a comparison of several risk scores: the Cohorte Lausannoise studyRémy Schmid, Peter Vollenweider, Gérard Waeber, et al.
Atherosclerosis|August 23, 2011
Association of statins with inflammatory cytokines: a population-based Colaus studyTanica Lyngdoh, Peter Vollenweider, Gérard Waeber, et al.
BMC Pharmacology & Toxicology|April 2, 2014
Antihypertensive drug treatment changes in the general population: the CoLaus studyVanessa Christe, Gérard Waeber, Peter Vollenweider, et al.
Cytokine|March 6, 2014
Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: a population-based study (CoLaus Study)Julien Vaucher, Pedro Marques-Vidal, Gérard Waeber, et al.
International Journal of Cardiology|August 14, 2012
Who is at low risk for cardiovascular disease? An assessment of different definitionsAntoine Gabioud, Gérard Waeber, Peter Vollenweider, et al.
Swiss Medical Weekly|April 5, 2008
Obesity in Switzerland: do estimates depend on how body mass index has been assessed?David Faeh, Pedro Marques-Vidal, Arnaud Chiolero, et al.
JACC. Advances|October 24, 2024
Associations Between Physical Activity Patterns and Cardiovascular Events and Risk Factors: Cross-Sectional and Prospective StudiesFabrizio Cominetti, Julien Vaucher, Pedro Marques-Vidal, et al.
The American Journal of Cardiology|December 24, 2022
Temporal Trends in Low-Dose Aspirin Use (from the CoLaus|PsyCoLaus Study)Elodie Drai, Pedro Marques-Vidal, Murielle Bochud, et al.
Pageof 108

Showing results (201-210 of 1,073) with videos related to

Sort By:
Pageof 108
Advanced Biomedical Research|March 11, 2026
Comparison of the 5-Year Incidence of Dyslipidemia in the Obese and Nonobese Adult Population: Results of the Yazd Health Study (YaHS)Parisa Peigan, Masoud Mirzaei, Pedro Marques-Vidal, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Soluble CD14 and Lipopolysaccharide-Binding Protein Are Not Superior to Soluble CD25 as Biomarkers for SarcoidosisSabine Ammann, Pedro Marques-Vidal, Matthieu Perreau, et al.
Diabetes Care|June 4, 2011
Estimating the risk of developing type 2 diabetes: a comparison of several risk scores: the Cohorte Lausannoise studyRémy Schmid, Peter Vollenweider, Gérard Waeber, et al.
Atherosclerosis|August 23, 2011
Association of statins with inflammatory cytokines: a population-based Colaus studyTanica Lyngdoh, Peter Vollenweider, Gérard Waeber, et al.
BMC Pharmacology & Toxicology|April 2, 2014
Antihypertensive drug treatment changes in the general population: the CoLaus studyVanessa Christe, Gérard Waeber, Peter Vollenweider, et al.
Cytokine|March 6, 2014
Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: a population-based study (CoLaus Study)Julien Vaucher, Pedro Marques-Vidal, Gérard Waeber, et al.
International Journal of Cardiology|August 14, 2012
Who is at low risk for cardiovascular disease? An assessment of different definitionsAntoine Gabioud, Gérard Waeber, Peter Vollenweider, et al.
Swiss Medical Weekly|April 5, 2008
Obesity in Switzerland: do estimates depend on how body mass index has been assessed?David Faeh, Pedro Marques-Vidal, Arnaud Chiolero, et al.
JACC. Advances|October 24, 2024
Associations Between Physical Activity Patterns and Cardiovascular Events and Risk Factors: Cross-Sectional and Prospective StudiesFabrizio Cominetti, Julien Vaucher, Pedro Marques-Vidal, et al.
The American Journal of Cardiology|December 24, 2022
Temporal Trends in Low-Dose Aspirin Use (from the CoLaus|PsyCoLaus Study)Elodie Drai, Pedro Marques-Vidal, Murielle Bochud, et al.
Pageof 108